Skip to main content

ProQR (PRQR) Receives a Buy from Evercore ISI

Tipranks - Tipranks - Thu Nov 6, 2025

In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on ProQR, with a price target of $5.00. The company’s shares closed yesterday at $2.38.

Meet Your ETF AI Analyst

According to TipRanks, Clark-Gartner is a 5-star analyst with an average return of 24.8% and a 70.10% success rate. Clark-Gartner covers the Healthcare sector, focusing on stocks such as Dianthus Therapeutics, Sarepta Therapeutics, and Insmed.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for ProQR with a $8.33 average price target, representing a 250.00% upside. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $12.00 price target.

See today’s best-performing stocks on TipRanks >>

PRQR market cap is currently $272.5M and has a P/E ratio of -5.84.

Read More on PRQR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).